PT  - JOURNAL ARTICLE
AU  - Trauer, Michael M
AU  - Matthies, Ashley
AU  - Mani, Nick
AU  - Mcdermott, Cian
AU  - Jarman, Robert
TI  - Utility of Lung Ultrasound in COVID-19: A Systematic Scoping Review
AID  - 10.1101/2020.06.15.20130344
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.15.20130344
4099  - http://medrxiv.org/content/early/2020/06/17/2020.06.15.20130344.short
4100  - http://medrxiv.org/content/early/2020/06/17/2020.06.15.20130344.full
AB  - Lung ultrasound (LUS) has an established evidence base and has proven useful in previous viral epidemics. An understanding of the utility of LUS in COVID-19 is crucial to determine its most suitable role based on local circumstances. A scoping review was thus undertaken to explore the utility of LUS in COVID-19 and guide future research.33 studies were identified which represent a rapidly expanding evidence base for LUS in COVID-19. The quality of the included studies was relatively low. However LUS appears to be a highly sensitive and fairly specific test for COVID-19 in all ages and in pregnancy and is almost certainly more sensitive than CXR. The precise diagnostic accuracy of LUS may be influenced by various factors including disease severity, pre-existing lung disease, scanning protocol, operator experience, disease prevalence and the reference standard.High quality research is needed in various fields including: diagnostic accuracy in undifferentiated patients; triage and prognostication; monitoring progression and guiding interventions; persistence of residual LUS findings; inter-observer agreement; and the role of contrast-enhanced LUS.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNO FUNDING RECEIVED BY ANY AUTHORAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:REVIEW ARTICLE SO NOT APPLICABLEAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesREVIEW ARTICLE SO NOT APPLICABLE